LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress
about
Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vectorBiomedical and clinical promises of human pluripotent stem cells for neurological disordersEstablishment of induced pluripotent stem cells from centenarians for neurodegenerative disease researchLeucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADPInhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutationThe role of oxidative stress in Parkinson's diseaseMutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesInduced neuronal cells: how to make and define a neuronAmniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesThe Application of Human iPSCs in Neurological Diseases: From Bench to BedsideThe Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseRecent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem CellsFunctional Evaluations of Genes Disrupted in Patients with Tourette's Disorder.Induced pluripotent stem cells for modeling neurological disordersEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsInduced pluripotent stem cells in Parkinson's disease: scientific and clinical challengesInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesΑlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's DiseaseUnderstanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patientsDeconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purposeCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsApplications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesUsing iPS Cells toward the Understanding of Parkinson's DiseaseAlzheimer's in 3D culture: challenges and perspectivesInduced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's diseasePatient-specific induced pluripotent stem cells in neurological disease modeling: the importance of nonhuman primate modelsCellular models to investigate biochemical pathways in Parkinson's diseaseiPSCs and small molecules: a reciprocal effort towards better approaches for drug discoveryLongitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseInduced pluripotent stem cells as a disease modeling and drug screening platformThe genomic stability of induced pluripotent stem cellsProceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex diseaseProgramming and Reprogramming Cellular Age in the Era of Induced PluripotencyModeling neurological disorders by human induced pluripotent stem cellsNeurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discoveryStem cells in the nervous systemModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsiPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's diseasePhysiological characterisation of human iPS-derived dopaminergic neuronsGeneration and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds
P2860
Q21134939-A4692249-E699-4693-8BE4-D9B1D7C47E85Q21284798-94D30FFB-9B31-483F-8F6F-A21C3F1DC445Q21560780-7A648E4C-D632-48B3-B48C-BE4AC517B006Q24293723-CB50BB9E-3CCC-4497-9A9E-978637251B33Q24297033-92921A92-E04A-421A-A120-5BD13D6C6A3CQ24307946-525A39A3-5F55-4D93-B5AA-3D1335BD78DBQ24318474-72C76F85-6628-4F88-A74F-43A1A5F6815DQ26269839-A82E171C-89AC-45B5-AC08-EFEF9CCF61D0Q26750573-28DBBF49-956D-4FB6-94C1-01E6028BDB49Q26765876-FC26DEEF-16EE-493C-A1CF-D8814DC4420BQ26765894-2D751FFE-93A7-4E54-BA94-34684279C24CQ26767096-2913AC75-9BEA-4945-A71D-5CBE4CEF0A14Q26768144-AFF510A1-B4A0-4677-8BBC-563AFE2688DAQ26771402-7434A5C2-454E-47A1-AEBC-B02956DF3DDFQ26772307-C37749AF-1CF8-4D2F-AEDD-656CB4741B16Q26772879-B9FB4A7B-B9DD-4769-985D-8D88E983A3EEQ26775061-E9E1529D-D43A-47AF-AA54-6B8CC0201614Q26778937-A0E8D24E-5CFC-49D5-B08C-2D68AA157698Q26784399-DE979BEE-1429-4B51-BE0C-13ABED865384Q26785491-382E8BB1-A156-4EDE-8F09-0F8286A8CB6DQ26798131-9CB77776-8F9D-4B69-AB76-37E0F9440361Q26799331-80D93883-7D7B-42D2-AE2B-43BF30A42973Q26799590-2D22590F-F7CE-4449-8FAF-0C5037185C07Q26801081-12352911-8D88-408F-917F-E62547FEC2E9Q26823333-265DE80F-B44E-4685-9674-887A57F0124FQ26825524-BACCA94A-057E-4BC7-A022-CE05F36AD762Q26829742-41F40F2B-604A-4ED1-A90C-DDDC5AD47866Q26865055-72CD7754-A56A-447E-80C2-1688A38C59D7Q26865220-46B94B2A-6AF3-43FF-8921-6021E99FB94FQ26865689-D4E662C6-F2DD-4CEC-9E5A-981845EDE43BQ26998764-D03DB842-99D6-484F-9177-C0F4DD349933Q26999033-0AFAC2F0-A8EE-4FE8-8947-03391F1B5E6CQ27008903-0D989BCB-CFA2-4729-BBBC-DECDE856428FQ27011777-F2D8503A-DBB0-4A10-89A3-6825D8186E2CQ27025493-1610A24F-7B89-408E-9F78-7BC36B498293Q27027574-B1EAB94B-EEEB-4CB6-8FCA-0E41449B458AQ27314983-75A57431-A35D-4ECE-AA55-2A683E87AE0DQ27321433-8D206A51-C2D0-434B-A4B6-054355BF0FC8Q27324718-0C8EE9BB-1F5E-4AEB-A7D7-D5DD6712007AQ27325858-5B319C8E-6EC9-4DB4-AEF9-671A9FFEB2E5
P2860
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@ast
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en-gb
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@nl
type
label
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@ast
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en-gb
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@nl
prefLabel
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@ast
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en-gb
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@nl
P2093
P2860
P921
P3181
P1433
P1476
LRRK2 mutant iPSC-derived DA n ...... eptibility to oxidative stress
@en
P2093
Aleksandr Shcheglovitov
Birgitt Schüle
Blake Byers
Branden Cord
Ha Nam Nguyen
James Byrne
Prachi Gujar
Renee Reijo Pera
Ricardo E Dolmetsch
Theo D Palmer
P2860
P304
P3181
P356
10.1016/J.STEM.2011.01.013
P407
P50
P577
2011-03-01T00:00:00Z